Macleods Pharmaceuticals Ltd — Levothyroxine Exporter Profile
Indian Pharmaceutical Exporter · #1 for Levothyroxine · $13.9M export value · DGFT Verified
Macleods Pharmaceuticals Ltd is the #1 Indian exporter of Levothyroxine with $13.9M in export value and 278 verified shipments. Macleods Pharmaceuticals Ltd holds a 17.9% market share in Levothyroxine exports across 14 countries.
Macleods Pharmaceuticals Ltd — Levothyroxine Export Profile: Buyers & Destinations
Where Does Macleods Pharmaceuticals Ltd Export Levothyroxine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.5M | 225 | 59.4% |
| CANADA | $1.2M | 49 | 29.1% |
| SRI LANKA | $143.5K | 4 | 3.5% |
| MYANMAR | $80.2K | 6 | 1.9% |
| HONDURAS | $56.0K | 11 | 1.3% |
| THAILAND | $50.0K | 2 | 1.2% |
| PERU | $47.9K | 1 | 1.2% |
| EL SALVADOR | $36.3K | 4 | 0.9% |
| SINGAPORE | $24.5K | 4 | 0.6% |
| VENEZUELA | $10.2K | 1 | 0.2% |
Macleods Pharmaceuticals Ltd exports Levothyroxine to 16 countries. The largest destination is UNITED STATES accounting for 59.4% of Macleods Pharmaceuticals Ltd's Levothyroxine shipments, followed by CANADA (29.1%) and SRI LANKA (3.5%). These destinations reflect Macleods Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Levothyroxine from Macleods Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| APOTEX INC. - SIGNET | CANADA | $785.2K | 33 |
| MACLEODS PHARMA USA INC | UNITED STATES | $673.3K | 65 |
| NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $527.0K | 22 |
| MACLEODS PHARMA USA,INC | UNITED STATES | $425.4K | 51 |
| APOTEX INC SIGNET 4100 WESTON ROAD | CANADA | $327.5K | 13 |
| MACLEODS PHARMA USA,INC, | UNITED STATES | $265.4K | 16 |
| MACLEODS PHARMA USA,INC.. | UNITED STATES | $249.5K | 42 |
| MACLEODS PHARMA USA, INC. | UNITED STATES | $153.9K | 6 |
| MACLEODS PHARMA USA, INC.,. | UNITED STATES | $140.8K | 8 |
| APOTEX | CANADA | $96.6K | 3 |
Macleods Pharmaceuticals Ltd supplies Levothyroxine to 35 buyers globally. The largest buyer is APOTEX INC. - SIGNET (CANADA), followed by MACLEODS PHARMA USA INC (UNITED STATES) and NORTHSTAR DISTRIBUTION CENTER 8912 (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Levothyroxine Export Value and How Much Does Macleods Pharmaceuticals Ltd Contribute?
India exported $60.1M worth of Levothyroxine through 2,385 shipments from 125 suppliers to 71 countries, serving 235 buyers globally. Macleods Pharmaceuticals Ltd contributes $13.9M to this total, accounting for 17.9% of India's Levothyroxine exports. Macleods Pharmaceuticals Ltd ships Levothyroxine to 16 countries through 35 buyers.
What Is the Average Shipment Value for Macleods Pharmaceuticals Ltd's Levothyroxine Exports?
Macleods Pharmaceuticals Ltd's average Levothyroxine shipment value is $50.0K per consignment, based on 278 shipments totaling $13.9M. The largest destination is UNITED STATES (59.4% of Macleods Pharmaceuticals Ltd's Levothyroxine exports).
How Does Macleods Pharmaceuticals Ltd Compare to Other Indian Levothyroxine Exporters?
Macleods Pharmaceuticals Ltd ranks #1 among 125 Indian Levothyroxine exporters with a 17.9% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($14.7M), MACLEODS PHARMACEUTICALS LTD ($13.9M), STERIL-GENE LIFE SCIENCES PRIVATE LIMITED ($9.4M). Macleods Pharmaceuticals Ltd processed 278 shipments to 14 destination countries.
What Levothyroxine Formulations Does Macleods Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES LEVOTHYROXINE SODIUM TABLETS USP 50 MCG | $139.0K | 9 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES LEVOTHYROXINE SODIUM TABLETS USP 125 MCG | $137.2K | 9 |
| DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES LEVOTHYROXINE SODIUM TABLETS USP 25 MCG | $113.0K | 6 |
| DRUGS AND PHARMACEUTICALS HARMLESS MEDICINES LEVOTHYROXINE SODIUM TABLETS USP 50MCG ( 1000 )- NDC NO. 72603-661-01 | $58.0K | 2 |
| LEVOTHYROXINE SODIUM TABLETS USP 100 MCG 1X1000 (8424 PAC) | $54.5K | 2 |
| THYROX 50MCG LEVOTHYROXINE 50MCG TABLETS 5X30S 17819 PAC | $50.0K | 1 |
| THYROX 100 (LEVOTHYROXINE TABLETS 100 MC | $50.0K | 1 |
| LEVOTHYROXINE SODIUM TABLETS USP 137 MCG1X1000S (1348 PAC) | $50.0K | 1 |
| LEVOTHYROXINE SODIUM TABLETS USP 125 MCG1X1000S (1326 PAC) | $50.0K | 1 |
| LEVOTHYROXINE SODIUM TABLETS USP 112 MCG1X1000S (1311 PAC) | $50.0K | 1 |
Macleods Pharmaceuticals Ltd exports 210 distinct Levothyroxine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DRUGS AND PHARMACEUTICALS HARMLESSMEDICINES LEVOTHYROXINE SO with 9 shipments worth $139.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Levothyroxine to Key Markets
What Macleods Pharmaceuticals Ltd must comply with to export Levothyroxine to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Canada — HC
Approval Process
ANDS (Abbreviated New Drug Submission) referencing Canadian Reference Product. Comparative bioavailability study required.
Timeline: 12–18 months
GMP & Export Requirements
Health Canada GMP (GUI-0001); Drug Establishment Licence (DEL) inspection
Drug Identification Number (DIN) for each product; Certificate of Pharmaceutical Product from CDSCO
Note: Subject to Good Import Practices and annual C.01.014.6 review.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Macleods Pharmaceuticals Ltd Compare to Nearest Levothyroxine Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | INTAS PHARMACEUTICALS LIMITED | $14.7M | 589 | 2 | $24.9K |
| 1 | MACLEODS PHARMACEUTICALS LTD ★ | $13.9M | 278 | 14 | $50.0K |
| 3 | STERIL-GENE LIFE SCIENCES PRIVATE LIMITED | $9.4M | 206 | 7 | $45.6K |
| 4 | WOCKHARDT LIMITED | $5.2M | 103 | 1 | $50.0K |
Macleods Pharmaceuticals Ltd ranks #1 among 125 Indian Levothyroxine exporters. Average shipment value of $50.0K compared to the market average of $481.0K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and STERIL-GENE LIFE SCIENCES PRIVATE LIMITED.
Which Indian Ports Ship Levothyroxine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 257 | 10.8% |
| MUNDRA SEA | 257 | 10.8% |
| DELHI AIR CARGO ACC (INDEL4) | 207 | 8.7% |
| NHAVA SHEVA SEA (INNSA1) | 207 | 8.7% |
| MUNDRA SEA (INMUN1) | 179 | 7.5% |
| SAHAR AIR | 165 | 6.9% |
| DELHI AIR | 120 | 5.0% |
| JNPT/ NHAVA SHEVA SEA | 98 | 4.1% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Levothyroxine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Levothyroxine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Macleods Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 324 individual customs records matching Macleods Pharmaceuticals Ltd exporting Levothyroxine, covering 210 formulations to 16 countries via 35 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 71+ countries, 235+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Levothyroxine Export Data from Macleods Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Macleods Pharmaceuticals Ltd's Levothyroxine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Macleods Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Levothyroxine Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Macleods Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Levothyroxine. For current shipment-level data, contact TransData Nexus.